NTLA ▲ +1.1% - Intellia Therapeutics, Inc. $NTLA Cathie Wood's ARK Investment buys 96.2K shares of Intellia Therapeutics today Intellia Therapeutics rose 1.1% today following news that Cathie Wood's ARK Investment Trust purchased 96,200 shares of the gene-editing company. The prominent investor's purchase signal confidence in NTLA's CRISPR-based therapeutic pipeline, which typically draws retail and institutional investors who follow ARK's high-conviction biotech positions. 02-SEP-2026 08:29 PM ET